Eswar Therapeutics Private Limited

Eswar Therapeutics Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24304CH2017PTC041467 Incorporated 05 April 2017 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹54.06 Cr
▲ 24% YoY
Net profit · FY 2025
₹1.29 Cr
Net margin 2.4%
EBITDA · FY 2025
₹2.74 Cr
EBITDA margin 5.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5.19 Cr
Satisfied ₹1.69 Cr
Company age
9 yrs
Est. 2017
Employees · EPFO
140
Provident fund records

About Eswar Therapeutics Private Limited

Data last updated:

Eswar Therapeutics Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 April 2017 and has been in existence for over 9 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304CH2017PTC041467. Its GSTIN is 04AAECE5982G1ZL (Chandigarh). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vikram Khungar (Managing Director) and Kashmiri Lal Khunger.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 4 – A Raipur Kalan, Chandigarh, India – 160102.

As per the financials filed for FY 2025, the company reported a revenue of ₹54.06 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.29 Cr (net margin 2.4%) and EBITDA of ₹2.74 Cr (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years and 25% over five years.

The company has about 140 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Eswar Therapeutics. As per MCA filings, the company has open charges of ₹5.19 Cr and satisfied charges of ₹1.69 Cr on record. Court records list 10 cases involving the company, including 2 filed by the company and 8 filed against it; 1 case is pending.

Eswar Therapeutics Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-CH-01-0003923). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website eswartherapeutics.com.

Company details

CIN U24304CH2017PTC041467
Registration Number 041467
Incorporation Date 05 April 2017
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-CH-01-0003923

Recognitions & Rankings of Eswar Therapeutics

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-CH-01-0003923

Contact details

Eswar Therapeutics Private Limited's registered office is in Chandigarh, Chandigarh. Its website is eswartherapeutics.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. 4 – A Raipur Kalan, Chandigarh, India – 160102
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Eswar Therapeutics Private Limited, buy the company report.

Comprehensive company report
Eswar Therapeutics Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Eswar Therapeutics operates one associated brand: Eswar Therapeutics. Each brand links to its own profile.

BrandDescriptionWebsite
Provision of pharmaceutical and nutritional products in India.eswartherapeutics.com

Business activity

The main business activity of Eswar Therapeutics is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Eswar Therapeutics Private Limited, buy the company report.

Financials of Eswar Therapeutics Private Limited

FY 2025 filings available

Eswar Therapeutics Private Limited reported revenue of ₹54.06 Cr (up 24% YoY) for FY 2025.

Revenue · FY 2025
₹54.06 Cr ▲ 24%
Net profit · FY 2025
₹1.29 Cr margin 2.4%
EBITDA · FY 2025
₹2.74 Cr margin 5.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 32%
5 years · compounded
▲ 25%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 39%
5 years · compounded
▲ 32%

Revenue has grown at a compounded annual rate (CAGR) of 25% over five years, including 24% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.74 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.29 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin5.1%
Net Profit Margin2.4%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Eswar Therapeutics Private Limited, buy the company report.

Board of directors of Eswar Therapeutics Private Limited

Eswar Therapeutics has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kashmiri Lal KhungerDirector28 Nov 20232 Years 11 MonthsCurrent
Vikram KhungarManaging Director25 Jan 20197 Years 9 MonthsCurrent
Raj KhuranaDirector01 Apr 20233 Years 7 MonthsCurrent

Peer comparison

Eswar Therapeutics Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Dezzey Sweeteners Private Limited₹54.1 Cr (FY 2025)-24.0%Indore, Madhya Pradesh, India
HMM Aluminium Private Limited₹54.09 Cr (FY 2025)11.0%Chandauli, Uttar Pradesh, India
Samit Sales Pvt Ltd₹54.09 Cr (FY 2024)3.0%Faridabad, Haryana, India
Laxmi Solar Power Systems Private Limited₹54.08 Cr (FY 2025)409.0%Raipur, Chhattisgarh, India
Nikunj Exports Private Limited₹54.06 Cr (FY 2025)-18.0%Rajasthan, India
Eswar Therapeutics Private Limitedthis company₹54.06 Cr (FY 2025)₹1.29 Cr2.4%24.0%140Chandigarh, India
Petra Industries Private Limited₹54.05 Cr (FY 2025)24.0%Bhavnagar, Gujarat, India
VPB Infratech Private Limited₹54.03 Cr (FY 2025)138.0%Jaipur, Rajasthan, India
Su-Dev Group Private Limited₹54.03 Cr (FY 2025)24.0%Ahmedabad, Gujarat, India
Ease Dealcom Private Limited₹54.03 Cr (FY 2025)209.0%Kolkata, West Bengal, India
Jinendra Enterprise Private Limited₹54.02 Cr (FY 2025)36.0%Ahmedabad, Gujarat, India

To see the full peer comparison of Eswar Therapeutics Private Limited, buy the company report.

Auditor

Eswar Therapeutics Private Limited is audited by NITIN MAHAJAN & ASSOCIATES for the financial year 2024.

Auditor firmFinancial yearFirm registration number
NITIN MAHAJAN & ASSOCIATESFY 2024019837N

Shareholding

The shareholding of Eswar Therapeutics Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2024FY 2023FY 2022FY 2021FY 2020
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Eswar Therapeutics Private Limited, buy the company report.

Charges & borrowings

Open charges
₹5.19 Cr
Satisfied charges
₹1.69 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹4.66 Cr
Uco Bank₹0.40 Cr
Indian Overseas Bank₹0.12 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Aug 2025101174374Indian Overseas Bank₹12 LakhOpen
28 Jul 2025101135228Hdfc Bank Limited₹5.76 LakhOpen
29 May 2025101104160Hdfc Bank Limited₹7.24 LakhOpen
21 Feb 2025101052220Hdfc Bank Limited₹8.36 LakhOpen
16 Dec 2024101030587Hdfc Bank Limited₹7 LakhOpen

To see the full charge records of Eswar Therapeutics Private Limited, buy the company report.

Total charge records: 20 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Eswar Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Eswar Therapeutics Private Limited has a workforce of 140 employees on its EPFO records as of Jan 22, 2025, across 1 active EPFO establishment.

Employee count
140
Active EPFO establishments
1
Employee growth
23.89%

GST

Eswar Therapeutics has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
04AAECE5982G1ZLChandigarhActive01 Jul 2017
02AAECE5982G1ZPHimachal PradeshActive03 Dec 2024

To see the full GST registrations and return filing status of Eswar Therapeutics Private Limited, buy the company report.

Recent activity

Eswar Therapeutics Private Limited has 8 board changes on record since 2019: 3 appointments and 5 cessations. The latest: Vikram Khungar ceased to be Director on 31 Mar 2025.

AGM
Eswar Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Indian Overseas Bank amounted to Rs. 12.00 Lakh with Charge ID 101174374 was registered on 30 Aug 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 5.76 Lakh with Charge ID 101135228 was registered on 28 Jul 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.24 Lakh with Charge ID 101104160 was registered on 29 May 2025.
Filing
Eswar Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chandigarh.
Ceased
Vikram Khungar ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.36 Lakh with Charge ID 101052220 was registered on 21 Feb 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.00 Lakh with Charge ID 101030587 was registered on 16 Dec 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.50 Lakh with Charge ID 101021699 was registered on 23 Oct 2024.
Ceased
Kashmiri Lal Khunger ceased to be Additional Director.
Charges
A charge with Hdfc Bank Limited of Rs. 380.00 Lakh registered on 05 May 2022 with Charge ID 100575767 was modified on 16 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 7.74 Lakh with Charge ID 100854765 was registered on 16 Dec 2023.

23 earlier events are in the company report.

Frequently asked questions

Eswar Therapeutics is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 April 2017 (9+ years old) and is registered under CIN U24304CH2017PTC041467.

Eswar Therapeutics has 3 current directors:

The latest financial statements of Eswar Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Eswar Therapeutics is 04AAECE5982G1ZL, registered in Chandigarh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAECE5982G1ZP (Himachal Pradesh).

The CIN (Corporate Identification Number) of Eswar Therapeutics is U24304CH2017PTC041467. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Eswar Therapeutics has 10 court cases on record: 2 filed by the company and 8 filed against it. 1 is pending. Most are in the district courts.

Eswar Therapeutics was incorporated on 05 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.

The peers of Eswar Therapeutics by revenue are Dezzey Sweeteners Private Limited, HMM Aluminium Private Limited, Samit Sales Pvt Ltd, Laxmi Solar Power Systems Private Limited, Nikunj Exports Private Limited and 5 more, all in the same principal business activity (wholesale trading).

Vikram Khungar ceased to be Director on 31 Mar 2025. Kashmiri Lal Khunger ceased to be Additional Director on 29 Sep 2024. Kashmiri Lal Khunger was appointed as Director on 28 Nov 2023. Eswar Therapeutics has 8 board changes on record in total.

Yes, Eswar Therapeutics is registered as a small enterprise under Udyam registration (number: UDYAM-CH-01-0003923).

Eswar Therapeutics can be reached through the website eswartherapeutics.com. Its registered office is in Chandigarh, India.